te beta cells. Type 1 diabetes currently affects 3 million
people in the United States, including Linda Broin who has suffered from
the disease for almost 30 years. It is an autoimmune disease in which the
body's immune system attacks and destroys insulin-producing cells of the
pancreas. It often strikes during childhood, makes patients dependent on
insulin for life and carries the constant threat of devastating
complications.
"Todd and Linda Broin believe the Sanford Project will bring them and
millions of others relief from this disease," added Krabbenhoft. "Through
the Sanford Project, our research team will hope to either spur the body to
copy existing functioning beta cells or to coax the pancreas to create new
ones. When people with the disease have regenerated beta cells, they can
begin making their own insulin again."
Regeneration research focuses on triggering the body to re-grow the
insulin-producing beta cells that have been killed by the autoimmune
response. It also works to prevent destruction of the newly regenerated
cells by the same autoimmune reaction. The intent of the Sanford Project
will be to focus on bench-side research and closely integrating
translational research opportunities with clinical treatment. The Sanford
Project is one of four initiatives outlined after a transformational gift
of $400 million by South Dakota businessman and philanthropist Denny
Sanford in 2007.
"I am absolutely thrilled by this extraordinary gift," stated Denny
Sanford. "Todd and Linda's amazing initiative and generosity has
established a great pace for accomplishment for the Sanford Project. This
will capture the attention of the best research scientist candidates from
around the world. I am grateful, touched and inspired by this extraordinary
leadership, and I add my heartfelt and sincere thanks along with the
millions who suffer with type 1 diabetes. Thank you, Todd and Linda Broin,
for jump starting the quest for the cure in such a dramatic
'/>"/>
SOURCE Sanford Health Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine technology :1.
Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes2.
Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer3.
Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test4.
VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy5.
Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women6.
Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease7.
Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign8.
Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies9.
Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression10.
Video: New Research Discovers Independent Brain Networks Control Human Walking11.
June 2008 Mayo Clinic Womens HealthSource Highlights Shingles Vaccine for Pain Prevention, Tips to Avoid Antibiotic Resistant Infections, and Benefits of Broad Genetic Testing